To our knowledge, this is the first time that ATM and 53BP1 have been assessed by immunohistochemistry in their activated phosphorylated state in a large, well-documented and consecutive series of patients with cervical cancer primarily treated with (chemo)radiation. Here, TP53BP1 is linked to cervical carcinoma.